Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

1145.03 (USD) • At close September 20, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990
Omzet 13,117.212,172.916,071.78,497.17,863.46,710.85,872.2274,860.4274,103.7282,819.5572,104.7451,378.477445.824459.074379.268238.457125.02463.44766.193174.01757.49721.98821.97359.27634.538.233.124.127.423.210.611.57.35
Kosten van de omzet 1,815.81,560.42,437.51,119.9782.2434.1397.061299.694392.709205.018155.35584.4554.2162.0931.6860.92308.1469.55715.2146.6766.4836.50915.5663.652.61.1000012.86.3
Brutowinst 11,301.410,612.513,634.27,377.27,081.26,276.75,475.1664,560.7333,711.0192,614.5391,949.391,294.022441.608456.981377.582237.534125.02455.30156.636158.80350.82115.50515.46443.7130.933.230.52327.423.210.611.5-5.5-1.3
Brutowinstmarge 0.8620.8720.8480.8680.9010.9350.9320.9380.9040.9270.9260.9390.9910.9950.9960.99610.8720.8560.9130.8840.7050.7040.7370.8960.8690.9210.9541111-0.753-0.26
Onderzoek- en ontwikkelingskosten 4,4393,592.52,908.12,7353,036.62,186.12,075.1422,052.2951,620.5771,271.353859.947625.554529.506489.252398.762278.016201.613137.064155.581136.095136.024124.92691.5456.25644.93727.828.323.339.70000
Algemene en administratieve kosten 000001,556.21,320.4331,177.697838.526504.755329.415210.755117.26165.20152.92349.34837.86525.89225.47617.06214.78512.5329.6078.3096.45.85.85.95.800000
Verkoop- en marketingkosten 0000000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2,631.32,115.91,824.91,3461,834.81,556.21,320.4331,177.697838.526504.755329.415210.755117.26165.20152.92349.34837.86525.89225.47617.06214.78512.5329.6078.3096.45.85.85.95.88.546.327.83.31.7
Overige kosten -20-89.9-45.6-280.4219.319.1-1.08-0.9260000000000-248.84200004.4213.434.46.15.94.23.120.80.3
Bedrijfskosten 7,068.25,618.54,687.43,800.64,871.43,742.33,395.5753,229.9922,459.1031,776.1081,189.362836.309646.767554.453451.685327.364239.478162.956-67.785153.157150.809137.458101.14768.98654.745.83840.33552.449.429.84.12
Bedrijfsresultaat 4,047.14,738.98,946.83,576.62,209.82,534.42,079.5911,330.7411,251.916838.431760.028457.713-205.159-97.472-74.103-89.83-114.454-107.655124.4215.646-99.988-121.953-85.683-25.276-23.8-12.6-7.5-17.3-7.6-29.2-38.8-18.3-9.6-3.3
Bedrijfsresultaat ratio 0.3090.3890.5570.4210.2810.3780.3540.2740.3050.2970.3610.332-0.46-0.212-0.195-0.377-0.915-1.6971.880.032-1.739-5.546-3.899-0.426-0.69-0.33-0.227-0.718-0.277-1.259-3.66-1.591-1.315-0.66
Totaal overige inkomsten en kosten netto -456.8119.9379233.8219.319.1-1.08-0.926-12.578-25.312-0.2312.0123.5492.1224.48817.22320.89716.54841.02148.2284.4629.43512.16-4.57514.4-3.4-14.3-14.70005.20
Inkomen voor belasting 4,199.34,858.89,325.83,810.42,429.12,553.52,078.5111,329.8151,225.097775.747713.36414.421-222.892-104.468-71.952-80.359-93.557-91.107124.42153.874-95.526-112.518-73.523-29.851-22.8-8.2-7.5-17.3-7.6000-4.40
Inkomen voor belasting ratio 0.320.3990.580.4480.3090.3810.3540.2740.2990.2750.3390.301-0.5-0.228-0.19-0.337-0.748-1.4361.880.31-1.661-5.117-3.346-0.504-0.661-0.215-0.227-0.718-0.277000-0.6030
Belastingkosten 245.7520.41,250.5297.2313.3109.1880434.293589.041427.673288.998-335.848-1.132-2.122-4.1222.351-29.751-21.866178.846-84.2813.008-7.011-21.6632.514-1.7-8.47.529.430.61.51.10.8-10.30
Nettowinst 3,953.64,338.48,075.33,513.22,115.82,444.41,198.511895.522636.056348.074424.362750.269-221.76-104.468-67.83-82.71-105.6-102.337-95.44641.699-107.458-124.377-76.18-23.215-23.1-8.6-11.6-32.4-23.5-30.7-39.9-19.1-4.5-3.3
Nettowinstmarge 0.3010.3560.5020.4130.2690.3640.2040.1840.1550.1230.2020.544-0.497-0.228-0.179-0.347-0.845-1.613-1.4420.24-1.869-5.657-3.467-0.392-0.67-0.225-0.35-1.344-0.858-1.323-3.764-1.661-0.616-0.66
WPA (Winst Per Aandeel) 37.0540.5176.432.6519.3821.2911.278.556.173.364.237.92-2.45-1.26-0.85-1.05-1.59-1.77-1.710.75-2.13-2.83-1.81-0.66-0.74-0.28-0.4-1.32-1.19-1.62-2.41-1.24-0.29-0.21
Verwaterde WPA 34.7738.2271.9730.5218.4621.2910.347.75.522.983.726.75-2.45-1.26-0.85-1.05-1.59-1.77-1.710.74-2.13-2.83-1.81-0.66-0.73-0.28-0.4-1.32-1.19-1.62-2.41-1.24-0.29-0.21
EBITDA 5,130.15,173.39,383.13,867.32,209.82,534.42,079.5911,330.7411,251.916838.431760.028457.713-205.159-97.472-59.856-89.83-123.864-109.61198.904-27.22-91.513-122.934-91.766-16.28-21.4-140.33.113-25-35.7-16.3-14-3
EBITDA ratio 0.3910.4250.5840.4550.2810.3780.3540.2740.3050.2970.3610.332-0.46-0.212-0.158-0.377-0.991-1.7281.494-0.156-1.592-5.591-4.176-0.275-0.62-0.3660.0090.1290.474-1.078-3.368-1.417-1.918-0.6